PIIND

What PI Industries promised, and what happened

Every commitment management made on a call, tracked from the quarter it was made — reaffirmed, revised, diluted or quietly dropped.

Guidance record · Q1 FY27

what the last two calls moved 16 tracked 1 delivered 5 missed 10 open
  • Consolidated EBITDA Margin delivered said Q4 FY25 Promised: Around 25% Q1 FY27: Deadline passed. The target was achieved for FY26.
  • Overall Revenue Growth missed said Q4 FY25 Promised: Mid single digit level growth this year (FY26) Q1 FY27: Deadline passed. The target was missed for FY26.
  • Pharma Business Profitability delayed said Q4 FY25 Promised: Positive trends in FY27-FY28 Q1 FY27: Pharma business reported a ₹60 crore EBITDA loss, confirming it is not yet profitable. Management reiterates the long gestation J-curve for CRDMO investments.

The rest of the ledger

Above is what the last two calls moved. Pro opens all 16 tracked commitments for PI Industries — every quarter's revision, the source quote behind each one, and the topics management has stopped answering.

See what Pro opens